Tuberculosis and COVID-19 Dually Affect Human Th17 Cell Immune Response

Tuberculosis and COVID-19 Dually Affect Human Th17 Cell Immune Response

COVID-19 infection not only profoundly impacts the detection of tuberculosis infection (Tbc) but also affects modality in tuberculosis patient immune response. It is important to determine immune response alterations in latent tuberculosis infection as well as in SARS-CoV-2-infected tuberculosis pat...

Full description

Bibliographic Details
Main Authors:	Anna Starshinova, Igor Kudryavtsev, Artem Rubinstein, Anna Malkova, Irina Dovgaluk, Dmitry Kudlay
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Biomedicines
Subjects:	tuberculosis pulmonary tuberculosis latent tuberculosis infection coronavirus infection COVID-19 SARS-CoV-2
Online Access:	https://www.mdpi.com/2227-9059/11/8/2123

Similar Items

Outcomes of latent tuberculosis infection treatment in Istanbul
by: Abdullah Emre Güner, et al.
Published: (2022-01-01)

High glycosylated hemoglobin level as a risk factor of latent tuberculosis infection in patients with uncomplicated type 2 diabetes mellitus
by: Yunita Arliny, et al.
Published: (2022-03-01)

Latent tuberculosis infection in the Polish prison staff
by: Aneta Filipek-Czerska, et al.
Published: (2021-08-01)

Association of Three SNPs Loci of Kelch-Like-ECH-Associated Protein 1 (Human) with Tuberculosis in Chinese Han Population
by: Wu S, et al.
Published: (2022-08-01)

Novel Biomarker Panel of Let-7d-5p and MiR-140-5p Can Distinguish Latent Tuberculosis Infection from Active Tuberculosis Patients
by: Liu J, et al.
Published: (2023-06-01)

Strengthening management of latent tuberculosis infection and accelerating the elimination of the tuberculosis epidemic
by: SHEN Xin, et al.
Published: (2023-03-01)

Response to: Socio-political prescriptions for latent tuberculosis infection are required to prevent reactivation of tuberculosis
by: Greg J. Fox, et al.
Published: (2017-05-01)

Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case)
by: A. Starshinova, et al.
Published: (2021-08-01)

PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
by: Maria Grazia Clemente, et al.
Published: (2017-04-01)

Lack of latent tuberculosis (TB) screening and delay in anti-retroviral therapy initiation in HIV-TB co-infection: an 11-year study in an intermediate TB-burden country
by: Vannesa Yue May Teng, et al.
Published: (2021-12-01)

Possibilities of Detecting an Epidemic Focus of Tuberculosis Infection in an Indicator Patient with a Positive Immunological Test for Tuberculosis
by: G. S. Oganezova, et al.
Published: (2023-11-01)

Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children
by: Magdalena Druszczynska, et al.
Published: (2021-04-01)

Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru
by: Chuan-Chin Huang, et al.
Published: (2020-03-01)

Evaluation of screening methods for the students who had close contact with pulmonary tuberculosis patients in Shanghai
by: XIAO Xiao, et al.
Published: (2023-03-01)

Implementation of the cascade of care for latent mycobacterium tuberculosis infection in people living with HIV/Aids
by: Kássia Raquel da Silva, et al.
Published: (2024-12-01)

Personalized early diagnosis and prediction of the tuberculosis infection course in children identifying predictors of latent tuberculosis infection and tuberculosis
by: M. A. Plekhanova, et al.
Published: (2021-02-01)

Construction of Immune-Related Diagnostic Model for Latent Tuberculosis Infection and Active Tuberculosis
by: Zhang Z, et al.
Published: (2024-04-01)

Latent tuberculosis infection status and its risk factors among tuberculosis-related health-care workers in Shanghai
by: RAO Lixin, et al.
Published: (2023-03-01)

Contribution of a IFN-y assay in contact tracing for tuberculosis in a low-incidence, high immigration area
by: M Metzger, et al.
Published: (2008-10-01)

Latent Tuberculosis Screening Using Electronic Health Record Data
by: Jeffrey D. Jenks, et al.
Published: (2020-09-01)

Clinical perspectives of childhood tuberculosis in Taiwan
by: Tzong-Shiann Ho, et al.
Published: (2011-12-01)

Diagnosis of Latent Tuberculosis Infection in Personnel of Various Institutions and Determination of the Risk Group for Tuberculosis
by: A. A. Starshinova, et al.
Published: (2019-09-01)

Management of children exposed to a patient with tuberculosis
by: Andreja Borinc Beden, et al.
Published: (2006-04-01)

Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015–2020)
by: Jaehee Lee, et al.
Published: (2024-06-01)

The incorporation of the 3HP regimen for tuberculosis preventive treatment in the Brazilian health system: a secondary-database nationwide analysis
by: Luiz Villarinho Pereira Mendes, et al.
Published: (2024-01-01)

Losses in the Care Cascade for Latent Tuberculosis Infection in the Tracing Contact Studies
by: Sofia Godoy, et al.
Published: (2023-11-01)

Features of tuberculosis diagnosis in the COVID-19
by: O. L. Ekaterincheva, et al.
Published: (2021-03-01)

The Use of Rifapentine for Preventive Chemotherapy in Children from Risk Groups of Developing Tuberculosis
by: O. D. Baronova, et al.
Published: (2022-09-01)

Safety and medical cost effectiveness of preventive treatment of children with latent tuberculosis infection
by: O. D. Baronova, et al.
Published: (2020-10-01)

Host Blood Transcriptional Signatures as Candidate Biomarkers for Predicting Progression to Active Tuberculosis
by: Chang Ho Kim, et al.
Published: (2023-04-01)

Comparison of Tuberculin Skin test and Quantiferon immunological assay for latent Tuberculosis infection
by: L.R. Codecasa, et al.
Published: (2005-09-01)

Smoking Exposure and the Risk of Latent Tuberculosis Infection: Results from NHANES 2011–2012
by: Xinsong Hu, et al.
Published: (2024-01-01)

Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination
by: P Godoy
Published: (2021-04-01)

Latent tuberculosis infection and infection-associated risk factors for miner workers with silicosis in eastern China
by: Xinsong Hu, et al.
Published: (2024-04-01)

Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis
by: Junseong Kim, et al.
Published: (2022-02-01)

Editorial: Factors for the progression from latent tuberculosis infection to tuberculosis disease
by: Cheng Chen, et al.
Published: (2023-06-01)

Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015
by: Maryam B. Haddad, et al.
Published: (2018-10-01)

Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis
by: I Frésard, et al.
Published: (2011-08-01)

Health care workers humoral immune response against GLcB, MPT51 and HSPX from Mycobacterium tuberculosis
by: Michelle Cristina Guerreiro dos Reis, et al.

Identification of apoptosis-related gene signatures as potential biomarkers for differentiating active from latent tuberculosis via bioinformatics analysis
by: Xiaoting Dai, et al.
Published: (2024-01-01)